Abstract
To investigate the outcomes of early diagnosis of recurrent cervical cancer after comprehensive and combined treatment. Materials and methods: The study utilized data from the comprehensive examination and treatment of 87 female patients with cervical cancer, who were treated at the Samarkand Branch of the Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology from 2021 to 2023. Various diagnostic methods, including radiological, clinical-laboratory, ultrasound, radiographic, morphological, and statistical approaches, were employed to achieve the research objectives. Based on the research goal and tasks, all patients were divided into two groups: the control group included 32 (36.78±5.17%) patients with cervical cancer who underwent comprehensive and combined treatment without recurrence for three years, and the second group comprised 55 (63.22±5.17%) patients with the same diagnosis, but with early recurrence detected after comprehensive and combined treatment at the preclinical stage. Patients were further classified into several subgroups.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.